ICOS Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICOS Corporation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (770)	6/5/2000 9:37:00 PM
From: Ian@SI	Read Replies (1) of 1139

Looks like the Abbott - TAP contender has picked up some bad press prior to approval... Perhaps there will be even more market share for Cialis than the analysts are currently estimating. Ian. +++++++++ An experimental impotence pill that could be the first challenger to Viagra is too dangerous to be allowed on the U.S. market, a consumer group said on Monday. Public Citizen urged the U.S. Food and Drug Administration to reject a bid by Illinois-based TAP Pharmaceuticals to sell the drug, Uprima, in the United States. The group pointed to clinical trials that showed side effects including fainting or drops in blood pressure in some men taking Uprima. TAP is a joint venture between ABBOTT LABS and Takeda Pharmaceuticals, a unit of Takeda Chemical Industries. Viagra is made by PFIZER INC.(Reuters 02:35 PM ET 06/05/2000)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next